170815 ⎘
Detection or diagnosis of diseases; Musculoskeletal or connective tissue disorders Osteoporosis
COMPOSITIONS AND METHODS UTILIZING A NOVEL HUMAN FOXO3 ISOFORM
#2COMPOSITIONS AND METHODS FOR EARLY DETECTION OF OSTEOPOROSIS
#3Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
#4Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
#5COMPOSITIONS AND METHODS UTILIZING A NOVEL HUMAN FOXO3 ISOFORM
#6DISEASE PREDICTING SYSTEM
#7Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
#8Therapeutic intervention for osteoporosis
#9BONE ACTIVE NITROGEN-CONTAINING BISPHOSPHONATES WITH A NEAR INFRARED FLUORESCENT LABEL
#10Methods to Diagnose, Treat and Prevent Bone Loss
#11Periostin fragments and use thereof
#12OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE
#13MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS
#14Methods to Diagnose, Treat and Prevent Bone Loss
#15POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#16OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE
#17SUSCEPTIBILITY TO BONE DAMAGE
#18Methods and monitoring of treatment with a WNT pathway inhibitor
#19COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS, CONTAINING PROGRANULIN INHIBITOR AS ACTIVE INGREDIENT
#20Methods to Diagnose Treat and Prevent Bone Loss
#21Siglec-15 antibodies in treating bone loss-related disease
#22Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#23Method for detecting and monitoring bone loss
#24SALIVARY BIOASSAY FOR EARLY DETECTION OF BONE LOSS
#25Methods for the prevention or treatment of scoliosis
#26METHODS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND BONE-RELATED DISEASES
#27Composition for preventing or treating fracture or osteoporosis using slit-robo system
#28Nucleic acids encoding anti-Siglec-15 antibodies
#29MEANS AND METHODS FOR ASSESSING BONE DISORDERS
#30Method for treating osteoporosis
#31Siglec-15 antibodies in treating bone loss-related disease
#32Methods of making antibodies that bind polypeptides involved in the process of bone remodeling
#33Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination
#34Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues
#35Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#36Methods of increasing bone mass in a subject comprising inhibiting DKK1
#37Siglec 15 antibodies in treating bone loss-related disease
#38EXAMINATION METHOD TO DETERMINE CONTRACTION OR ACTIVITY OF DISEASES RELATED IMMUNE SYSTEM OR JOINT SYSTEM
#39Salivary Bioassay for Early Detection of Bone Loss
#40METHODS OF IDENTIFYING OBM MODULATORS
#41NOVEL USE OF CA-125
#42Antibodies that bind polypeptides involved in the process of bone remodeling
#43Polynucleotides encoding antibodies against sclerostin and uses therefor
#44METHOD FOR SCREENING OSTEOPONTIN INHIBITOR AND INHIBITOR OBTAINED FROM THE METHOD
#45Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
#46Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
#47SUSCEPTIBILITY TO BONE DAMAGE
#48DETECTION AND/OR TREATMENT OF DISEASES ASSOCIATED WITH AUTOANTIBODIES
#49Methods to diagnose treat and prevent bone loss
#50Methods of using GPR119 receptor to identify compounds which stimulate glucose-dependent insulinotropic peptide secretion
#51RSPONDIN-3 INHIBITION IN BONE DISORDERS
#52Antibodies that bind polypeptides involved in the process of bone remodeling
#53ActRIIB FUSION POLYPEPTIDES AND USES THEREFOR
#54NELL-1 enhanced bone mineralization
#55METHODS OF TREATMENT USING BIASED LIGANDS FOR RECEPTORS SUCH AS THE PTH RECEPTOR
#56Methods of treating bone mass diseases
#57Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
#58Compositions and methods for use for antibodies against sclerostin
#59SUSCEPTIBILITY TO BONE DAMAGE
#60Serum Prolactin Binding Protein in Epithelial Carcinoma
#61Structure of the insulin receptor ectodomain
#62GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF
#63METHODS OF USING A G PROTEIN-COUPLED RECEPTOR TO IDENTIFY PEPTIDE YY (PYY) SECRETAGOGUES AND COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MODULATED BY PYY
#64Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
#65Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues
#66Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues
#67Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues
#68Compositions and methods for improving bone mass through modulation of receptors of PTH and fragments thereof
#69Altered Activity of Toll-Like Receptors
#70Compositions and methods for increasing bone mineralization
#71ANTIBODIES THAT BIND TO OBM
#72Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
#73Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#74Osteopenia animal model
#75METHOD OF DETERMINING THE RISK OF SCOLIOSIS
#76Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
#77METHODS, KITS, AND ANTIBODIES FOR QUANTITATIVE DETERMINATION OF PARATHYROID HORMONE MOLECULES WITH INTACT C-TERMINUS
#78MUTATIONS IN CAPILLARY MORPHOGENESIS GENE-2 (CMG-2) AND USE THEREOF
#79Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#80METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS
#81Novel Monoclonal Anitbody and Use thereof
#82OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE THEREOF
#83Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
#84EXPRESSION OF ORPHAN GPR64 IN INFLAMMATORY DISEASES
#85Compositions and methods for use for antibodies against sclerostin
#86ActRIIB Fusion Polypeptides and Uses Therefor
#87METHODS OF TREATING BONE DISORDERS WITH MODULATORS OF AXL
#88ActRIIB Fusion Polypeptides and Uses Therefor
#89Bone/joint disease sensitivity gene and use thereof
#90MODULATION OF BONE FORMATION
#91Biased Ligands for Receptors Such as the PTH Receptor
#92Oasis gene-deficient mouse
#93SUSCEPTIBILITY TO BONE DAMAGE
#94Methods For Measuring Bone Formation
#95NELL-1 enhanced bone mineralization
#96Methods of controlling bone loss by inhibiting DKK1
#97Antibodies to OCIF-binding molecules
#98Methods and apparatus for multi dimension fluorescence spectrum measurement downhole
#99Osteoporosis associated markers and methods of use thereof
#100Parathyroid hormone antagonists and uses thereof
#101ActRIIB Fusion Polypeptides and Uses Therefor
#102Methods, kits, and antibodies for detecting parathyroid hormone
#103Applications of kidney secreted bone growth factor and pharmaceutical use of flavonol and flavonol glycosides for stimulating the secretion of kidney secreted bone growth factor
#104Methods, kits, and antibodies for detecting parathyroid hormone
#105GDF-9/BMP-15 modulators for the treatment of bone disorders
#106Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
#107Methods, agents, and compound screening assays for inducing differentiation of undifferentiatied mammalian cells into osteoblasts
#108Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
#109Serum Prolactin Binding Protein in Epithelial Carcinoma
#110Cynomolgus monkey dickkopf-4, nucleotides encoding same, and uses thereof
#111Antibody targeting osteoclast-associated protein
#112Molecular determinants of myeloma bone disease and use thereof
#113Computer systems and methods for inferring casuality from cellular constituent abundance data
#114Inhibitors targeting osteoclast-associated protein
#115Antibodies to OCIF-binding molecules
#116Modulation of osteoblast activity by fhl2
#117Computer systems and methods for inferring causality from cellullar constituent abundance data
#118Antibodies specific for sclerostin
#119Compositions and methods for bone formation and remodeling
#120Model of bone disease amenable to high-throughput screening
#121Compounds and therapies for the prevention of vascular and non-vascular pathologies
#122Methods of treating and preventing bone loss
#123Methods and compositions to promote bone homestasis
#124Methods and compositions to promote bone homeostasis
#125Mutations in capillary morphogenesis gene-2 (CMG-2) and use thereof
#126Novel protein and method for producing the protein
#127Functional method for generating or screening for ligands which modulate steroid hormone receptors
#128Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
#129Compositions and methods for bone formation and remodeling
#130Methods and agents for enhancing bone formation or preventing bone loss
#131Method and compositions for promoting osteogenesis
#132Mouse model for bone metabolism
#133Compounds and therapies for the prevention of vascular and non-vascular pathologies
#134Antibodies to OCIF-binding molecules
#135System and method for bone loss assay